16.92
1.28%
-0.22
After Hours:
16.92
Zenas Biopharma Inc stock is traded at $16.92, with a volume of 136.32K.
It is down -1.28% in the last 24 hours and up +0.00% over the past month.
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
See More
Previous Close:
$17.14
Open:
$17.17
24h Volume:
136.32K
Relative Volume:
6.16
Market Cap:
$673.29M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.98%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Zenas Biopharma Inc Stock (ZBIO) Latest News
IgG4-related Disease Market to Show Remarkable Growth Trends - openPR
Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.
Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN
Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com Canada
Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com
Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India
Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com UK
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - The Korea Bizwire
Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - ForexTV.com
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase ... - The Bakersfield Californian
Zenas BioPharma Announces Closing of Full Exercise of - GlobeNewswire
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in - EIN News
Upstream Bio goes public amid spate of IPOs - The Pharma Letter
Zenas BioPharma Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in… - Informazione.it
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com South Africa
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Australia
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com India
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com UK
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director acquires $999k in company stock - Investing.com Canada
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Australia
Zenas BioPharma director acquires $999k in company stock - Investing.com
Zenas BioPharma director acquires $999k in company stock - Investing.com India
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com UK
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com UK
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com Canada
Zenas BioPharma director buys $7.48m in company stock - Investing.com
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com Australia
Zenas BioPharma director buys $7.48m in company stock - Investing.com India
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock By Investing.com - Investing.com South Africa
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com UK
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com India
Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com Canada
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com India
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Australia
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Canada
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com India
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com UK
MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip
Biotech IPO Shares Climb in Trading Debuts After Deals Upsized - MSN
Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News
Trio of first-day pops may bode well for biotech IPO window - BioCentury
Biotech Startups Make Pre-Election Sprint to the Public Markets - The Wall Street Journal
2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360
Biotech trio revives the IPO market - Axios
Zenas Biopharma Inc Stock (ZBIO) Financials Data
There is no financial data for Zenas Biopharma Inc (ZBIO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):